Skip to main content
. Author manuscript; available in PMC: 2014 Apr 4.
Published in final edited form as: J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):162–167. doi: 10.1097/QAI.0b013e31819388a9

TABLE 2.

Proportion of Participants Who Used Saliva as a Lubricant During Penile–Anal Intercourse in the Prior 6 Months, According to Participant and Partner HIV Infection Status

Role of Participants Participant HIV
Infection Status
Partner HIV
Infection Status*
No. Participants
Engaging in
Act With Partner
No. (%) Participants
Reporting Saliva Use as
a Lubricant During Act
Odds Ratio
(95% CI)
P
Insertive Infected Uninfected 15 1 (6.7) Reference
Infected Infected 21 12 (57.1) 13.5 (2.0 to 89.4) 0.007
Uninfected Uninfected 112 50 (44.6) Reference
Uninfected Infected 32 10 (31.3) 0.62 (0.30 to 1.3) 0.20
Receptive§ Infected Uninfected 20 6 (30.0) Reference
Infected Infected 25 18 (72.0) 5.4 (1.9 to 15.3) 0.002
Uninfected Uninfected 115 45 (39.1) Reference
Uninfected Infected 23 5 (21.7) 0.45 (0.19 to 1.04) 0.06
*

Denotes participants’ perception of partners’ HIV infection status.

As estimated by generalized estimating equations.

For each partner type, participants were asked “In the last 6 months, with how many men did you put penis in the man’s rectum (with or without a condom)?” For men who indicated that they had had insertive anal intercourse within the past 6 months, the following question was asked: "With how many of these men did you use your own saliva as a lubricant (“lube”)?

§

For each partner type, participants were asked “In the last 6 months, with how many men put their penis in your rectum (with or without a condom)?” For men who indicated that they had had receptive anal intercourse within the past 6 months, the following question was asked: "How many of these men used their own saliva as a lubricant (“lube”)?